Synergistic Effects of Acyclovir and Curcumin on Herpes Simplex Virus Type 1
Future Natural Products · 18.02.2026 · 11 (1) · 4-9
DOI: 10.34172/fnp.322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Natural Products, online erschienen am 18.02.2026. Verfasst von Maryam Reisi und 5 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Introduction
The emergence of drug-resistant viral strains has emphasized the need for natural antiviral compounds with fewer side effects. Curcumin, a natural polyphenol, exhibits antiviral, antioxidant, antitumor, and anti-inflammatory activities. Considering that drug combinations can reduce resistance development and cytotoxicity by lowering effective doses, this study aimed to evaluate the synergistic effects of curcumin combined with acyclovir against herpes simplex virus type 1 (HSV-1) in vitro.
Methods
In this experimental study, the cytotoxicity of curcumin and acyclovir was assessed on Vero cells using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Moreover, the antiviral activity of curcumin and acyclovir alone, as well as acyclovir combined with the 10% cytotoxic concentration (CC10) of curcumin, was evaluated using MTT and 50% tissue culture infective dose assays, and the 50% inhibitory concentration (IC50) underwent calculation. Ultimately, synergistic effects were analyzed by determining viral growth inhibition percentages at various drug concentrations, and the combination index was computed using CompuSyn 1.0.
Results
The CC50 values of acyclovir and curcumin were 537.7 µM and 74.44 µM, respectively. Furthermore, the IC50 values were 0.395, 12.6 µM, and 0.144 µM for acyclovir, curcumin, and the combination of acyclovir with 20 µM (CC10) curcumin, respectively. Both compounds significantly reduced viral titers individually and in combination. Finally, the combined treatment demonstrated a synergistic antiviral effect at the tested concentrations.
Conclusion
Overall, curcumin had notable antiviral activity against HSV-1 in vitro and substantially enhanced acyclovir’s antiviral efficacy through synergistic interaction, suggesting potential for future clinical evaluations.
Zitieren
APA
Reisi, M., Hafizi, M., Khosravian, P., Altememy, D., Javadi-Farsani, F., & Moradi, M. (2026). Synergistic Effects of Acyclovir and Curcumin on Herpes Simplex Virus Type 1. Future Natural Products, 11(1), 4-9. https://doi.org/10.34172/fnp.322
Vancouver
Reisi M, Hafizi M, Khosravian P, Altememy D, Javadi-Farsani F, Moradi M. Synergistic Effects of Acyclovir and Curcumin on Herpes Simplex Virus Type 1. Future Natural Products. 2026;11(1):4-9. doi:10.34172/fnp.322
BibTeX
@article{Reisi2026,
author = {Reisi, Maryam and Hafizi, Masoud and Khosravian, Pegah and Altememy, Dhiya and Javadi-Farsani, Fatemeh and Moradi, Mohammad-Taghi},
title = {Synergistic Effects of Acyclovir and Curcumin on Herpes Simplex Virus Type 1},
journal = {Future Natural Products},
year = {2026},
volume = {11},
number = {1},
pages = {4--9},
doi = {10.34172/fnp.322}
}
EUVIMED